Honorary Professor

Kum Kum Khanna

Email: 

Availability

Honorary Professor Kum Kum Khanna is:
Available for supervision

Fields of research

Biological Sciences Oncology and carcinogenesis

Search Professor Kum Kum Khanna’s works on UQ eSpace

207 works between 1995 and 2026
All (207) Journal Article (193) Other Outputs (1) Conference Publication (13)

201 - 207 of 207 works

1997

Journal Article

Interaction between ATM protein and c-Abl in response to DNA damage

Shafman, T, Khanna, KK, Kedar, P, Spring, K, Kozlov, S, Yen, T, Hobson, K, Gatei, M, Zhang, N, Watters, D, Egerton, M, Shiloh, Y, Kharbanda, S, Kufe, D and Lavin, MF (1997). Interaction between ATM protein and c-Abl in response to DNA damage. Nature, 387 (6632), 520-523. doi: 10.1038/387520a0

Interaction between ATM protein and c-Abl in response to DNA damage

1997

Journal Article

Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms

Watters, D, Khanna, KK, Beamish, H, Birrell, G, Spring, K, Kedar, P, Gatei, M, Stenzel, D, Hobson, K, Kozlov, S, Zhang, N, Farrell, A, Ramsay, J, Gatti, R and Lavin, M (1997). Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene, 14 (16), 1911-1921. doi: 10.1038/sj.onc.1201037

Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms

1997

Journal Article

Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells

Khanna, KK, Yan, J, Watters, D, Hobson, K, Beamish, H, Spring, K, Shiloh, Y, Gatti, RA and Lavin, MF (1997). Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells. Journal of Biological Chemistry, 272 (14), 9489-9495. doi: 10.1074/jbc.272.14.9489

Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells

1997

Journal Article

Isolation of full-length ATM cDNA and correction of the ataxia- telangiectasia cellular phenotype

Zhang, N., Chen, P., Khanna, K.K., Scott, S., Gatei, M., Kozlov, S., Watters, D., Spring, K., Yen, T. and Lavin, M.F. (1997). Isolation of full-length ATM cDNA and correction of the ataxia- telangiectasia cellular phenotype. Proceedings of the National Academy of Sciences of the United States of America, 94 (15), 8021-8026. doi: 10.1073/pnas.94.15.8021

Isolation of full-length ATM cDNA and correction of the ataxia- telangiectasia cellular phenotype

1996

Journal Article

Induction of inositol 1,4,5 trisphosphate receptor genes by ionizing radiation

Yan, J, Khanna, KK and Lavin, MF (1996). Induction of inositol 1,4,5 trisphosphate receptor genes by ionizing radiation. International Journal of Radiation Biology, 69 (5), 539-546. doi: 10.1080/095530096145544

Induction of inositol 1,4,5 trisphosphate receptor genes by ionizing radiation

1996

Journal Article

Genetic complementation of radiation response by 3′ untranslated regions (UTR) of RNA

Chen, P., Girjes, A. A., Hobson, K., Beamish, H., Khanna, K. K., Farrell, A., Gatei, M., Teale, B., Buchwald, M., Legerski, R. and Lavin, M. F. (1996). Genetic complementation of radiation response by 3′ untranslated regions (UTR) of RNA. International Journal of Radiation Biology, 69 (3), 385-395. doi: 10.1080/095530096145940

Genetic complementation of radiation response by 3′ untranslated regions (UTR) of RNA

1995

Journal Article

Nature of G1/s cell-cycle checkpoint defect in ataxia-telangiectasia

Khanna, KK, Beamish, H, Yan, J, Hobson, K, Williams, R, Dunn, I and Lavin, MF (1995). Nature of G1/s cell-cycle checkpoint defect in ataxia-telangiectasia. Oncogene, 11 (4), 609-618.

Nature of G1/s cell-cycle checkpoint defect in ataxia-telangiectasia

Current funding

  • 2026 - 2028
    Optimisation of endometrial cancer treatment using ex vivo Patient-Derived Organoids/tumouroids.
    Mary Elizabeth Courier Research Scholarship
    Open grant
  • 2026 - 2029
    Targeting PP2A to sensitize ovarian cancers to immune checkpoint blockade therapy
    Ovarian Cancer Research Foundation Research Grants
    Open grant
  • 2024 - 2026
    Targeting the redox niche in triple-negative breast cancer to treat brain metastases
    National Breast Cancer Foundation Investigator Initiated Research Scheme
    Open grant
  • 2024 - 2027
    Targeting metstatic breast cancer by oligonucleotide therapeutics with the FDA lipid nanoparticles (LNP) delivery system.
    National Breast Cancer Foundation Investigator Initiated Research Scheme
    Open grant
  • 2022 - 2026
    Targeting CEP55 in Triple-Negative Breast Cancer (US DoD CDMRP grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant

Past funding

  • 2024
    Exploitation of immunogenicity of Cep 55 to enhance efficacy of therapy for triple-negative breast cancer
    National Breast Cancer Foundation Investigator Initiated Research Scheme
    Open grant

Availability

Honorary Professor Kum Kum Khanna is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Discovering therapies of metastatic and recurrenttriple-negative breast cancer using next generation 3D models

    Principal Advisor

  • Doctor Philosophy

    Optimising systemic therapies of metastatic and recurrent triple-negative breast cancer using next generation 3D models

    Principal Advisor

  • Doctor Philosophy

    Functional validation of therapeutic targets for basal breast cancer

    Principal Advisor

  • Doctor Philosophy

    Drug Repurposing for Biomarker Discovery and Therapeutic Sensitisation in Triple Negative Breast Cancer (TNBC) and High Grade Serous Ovarian Cancer (HGSOC)

    Principal Advisor

  • Doctor Philosophy

    A mitotic switch: serine 125 phosphorylation of MLKL links cell division to cell fate

    Principal Advisor

  • Doctor Philosophy

    Breaking barriers: unlocking the potential of cytomegalovirus-specific T cells in allogeneic CAR T cell therapies

    Associate Advisor

    Other advisors: Honorary Professor Rajiv Khanna

  • Doctor Philosophy

    Designing Therapeutic Strategies Targeting KRAS

    Associate Advisor

    Other advisors: Honorary Professor Rajiv Khanna

  • Doctor Philosophy

    Investigating the diagnostic and functional significance of specific epigenomic features in triple-negative breast cancer (TNBC)

    Associate Advisor

    Other advisors: Dr Jodi Saunus

Completed supervision

Enquiries

For media enquiries about Honorary Professor Kum Kum Khanna's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au